Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Meral Beksac

Showing results (1-10 of 185) with videos related to

Pageof 19
Sort By:
Frontiers in Medicine|January 22, 2016
Is There Any Reason to Prefer Cord Blood Instead of Adult Donors for Hematopoietic Stem Cell Transplants?Meral Beksac
Frontiers in Medicine|March 1, 2016
How to Improve Cord Blood Engraftment?Meral Beksac, Pinar Yurdakul
Clinical Hematology International|October 1, 2021
Natural Killer Cell-Mediated Cellular Therapy of Hematological MalignanciesUgur Sahin, Meral Beksac
Methods in Molecular Medicine|August 2, 2007
Sequence-specific primed PCR (PCR-SSP) typing of HLA Class I and Class II allelesKlara Dalva, Meral Beksac
Methods in Molecular Medicine|August 2, 2007
HLA typing with sequence-specific oligonucleotide primed PCR (PCR-SSO)and use of the Luminex technologyKlara Dalva, Meral Beksac
Methods in Molecular Medicine|August 2, 2007
Identification of bone marrow derived nonhematopoietic cells by double labeling with immunohistochemistry and in situ hybridizationIsinsu Kuzu, Meral Beksac
Methods in Molecular Biology (Clifton, N.J.)|January 30, 2014
HLA typing with sequence-specific oligonucleotide primed PCR (PCR-SSO) and use of the Luminex™ technologyKlara Dalva, Meral Beksac
Frontiers in Oncology|March 14, 2022
Is Quantification of Measurable Clonal Plasma Cells in Stem Cell Grafts (gMRD) Clinically Meaningful?Guldane Cengiz Seval, Meral Beksac
Expert Opinion on Drug Safety|August 18, 2018
The safety of bortezomib for the treatment of multiple myelomaGuldane Cengiz Seval, Meral Beksac
Expert Opinion on Drug Safety|May 10, 2019
A comparative safety review of histone deacetylase inhibitors for the treatment of myelomaGuldane Cengiz Seval, Meral Beksac
Pageof 19

Showing results (1-10 of 185) with videos related to

Sort By:
Pageof 19
Frontiers in Medicine|January 22, 2016
Is There Any Reason to Prefer Cord Blood Instead of Adult Donors for Hematopoietic Stem Cell Transplants?Meral Beksac
Frontiers in Medicine|March 1, 2016
How to Improve Cord Blood Engraftment?Meral Beksac, Pinar Yurdakul
Clinical Hematology International|October 1, 2021
Natural Killer Cell-Mediated Cellular Therapy of Hematological MalignanciesUgur Sahin, Meral Beksac
Methods in Molecular Medicine|August 2, 2007
Sequence-specific primed PCR (PCR-SSP) typing of HLA Class I and Class II allelesKlara Dalva, Meral Beksac
Methods in Molecular Medicine|August 2, 2007
HLA typing with sequence-specific oligonucleotide primed PCR (PCR-SSO)and use of the Luminex technologyKlara Dalva, Meral Beksac
Methods in Molecular Medicine|August 2, 2007
Identification of bone marrow derived nonhematopoietic cells by double labeling with immunohistochemistry and in situ hybridizationIsinsu Kuzu, Meral Beksac
Methods in Molecular Biology (Clifton, N.J.)|January 30, 2014
HLA typing with sequence-specific oligonucleotide primed PCR (PCR-SSO) and use of the Luminex™ technologyKlara Dalva, Meral Beksac
Frontiers in Oncology|March 14, 2022
Is Quantification of Measurable Clonal Plasma Cells in Stem Cell Grafts (gMRD) Clinically Meaningful?Guldane Cengiz Seval, Meral Beksac
Expert Opinion on Drug Safety|August 18, 2018
The safety of bortezomib for the treatment of multiple myelomaGuldane Cengiz Seval, Meral Beksac
Expert Opinion on Drug Safety|May 10, 2019
A comparative safety review of histone deacetylase inhibitors for the treatment of myelomaGuldane Cengiz Seval, Meral Beksac
Pageof 19